| Year |
Citation |
Score |
| 2024 |
Galeano D, Haltom J, Andolino C, Yousey A, Zaksas V, Das S, Baylin SB, Wallace DC, Slack FJ, Enguita FJ, Wurtele ES, Teegarden D, Meller R, Cifuentes D, Beheshti A. sChemNET: a deep learning framework for predicting small molecules targeting microRNA function. Nature Communications. 15: 9149. PMID 39443444 DOI: 10.1038/s41467-024-49813-w |
0.417 |
|
| 2024 |
Mohd ON, Heng YJ, Wang L, Thavamani A, Massicott ES, Wulf GM, Slack FJ, Doyle PS. Sensitive Multiplexed MicroRNA Spatial Profiling and Data Classification Framework Applied to Murine Breast Tumors. Analytical Chemistry. PMID 39044395 DOI: 10.1021/acs.analchem.4c01773 |
0.361 |
|
| 2023 |
Naderi Yeganeh P, Teo YY, Karagkouni D, Pita-Juárez Y, Morgan SL, Slack FJ, Vlachos IS, Hide WA. PanomiR: a systems biology framework for analysis of multi-pathway targeting by miRNAs. Briefings in Bioinformatics. 24. PMID 37985452 DOI: 10.1093/bib/bbad418 |
0.449 |
|
| 2023 |
Li C, Yoon B, Stefani G, Slack FJ. Lipid kinase PIP5K1A regulates let-7 microRNA biogenesis through interacting with nuclear export protein XPO5. Nucleic Acids Research. PMID 37655623 DOI: 10.1093/nar/gkad709 |
0.457 |
|
| 2023 |
Kasina V, Wahane A, Liu CH, Yang L, Nieh MP, Slack FJ, Bahal R. Next-generation poly-L-histidine formulations for miRNA mimic delivery. Molecular Therapy. Methods & Clinical Development. 29: 271-283. PMID 37123088 DOI: 10.1016/j.omtm.2023.03.015 |
0.451 |
|
| 2023 |
Matai L, Slack FJ. MicroRNAs in Age-Related Proteostasis and Stress Responses. Non-Coding Rna. 9. PMID 37104008 DOI: 10.3390/ncrna9020026 |
0.383 |
|
| 2023 |
Matai L, Stathis T, Lee JD, Parsons C, Saxena T, Shlomchik K, Slack FJ. The conserved microRNA-229 family controls low-insulin signaling and dietary restriction induced longevity through interactions with SKN-1/NRF2. Aging Cell. e13785. PMID 36748780 DOI: 10.1111/acel.13785 |
0.347 |
|
| 2022 |
Dhuri K, Pradeep SP, Shi J, Anastasiadou E, Slack FJ, Gupta A, Zhong XB, Bahal R. Simultaneous Targeting of Multiple oncomiRs with Phosphorothioate or PNA-Based Anti-miRs in Lymphoma Cell Lines. Pharmaceutical Research. PMID 36071352 DOI: 10.1007/s11095-022-03383-y |
0.514 |
|
| 2022 |
Zhang WC, Skiados N, Aftab F, Moreno C, Silva L, Corbilla PJA, Asara JM, Hata AN, Slack FJ. MicroRNA-21 guide and passenger strand regulation of adenylosuccinate lyase-mediated purine metabolism promotes transition to an EGFR-TKI-tolerant persister state. Cancer Gene Therapy. PMID 35840668 DOI: 10.1038/s41417-022-00504-y |
0.381 |
|
| 2022 |
Baker AR, Miliotis C, Ramírez-Moya J, Marc T, Vlachos IS, Santisteban P, Slack FJ. Transcriptome profiling of ADAR1 targets in triple-negative breast cancer cells reveals mechanisms for regulating growth and invasion. Molecular Cancer Research : McR. PMID 35247916 DOI: 10.1158/1541-7786.MCR-21-0604 |
0.307 |
|
| 2021 |
Haswell JR, Mattioli K, Gerhardinger C, Maass PG, Foster DJ, Peinado P, Wang X, Medina PP, Rinn JL, Slack FJ. Genome-wide CRISPR interference screen identifies long non-coding RNA loci required for differentiation and pluripotency. Plos One. 16: e0252848. PMID 34731163 DOI: 10.1371/journal.pone.0252848 |
0.63 |
|
| 2021 |
Lee SM, Kaye KM, Slack FJ. Cellular microRNA-127-3p suppresses oncogenic herpesvirus-induced transformation and tumorigenesis via down-regulation of SKP2. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34725152 DOI: 10.1073/pnas.2105428118 |
0.393 |
|
| 2021 |
Dhuri K, Gaddam RR, Vikram A, Slack FJ, Bahal R. Therapeutic potential of chemically modified, synthetic, triplex peptide nucleic acid-based oncomiR inhibitors for cancer therapy. Cancer Research. PMID 34548334 DOI: 10.1158/0008-5472.CAN-21-0736 |
0.353 |
|
| 2021 |
Peinado P, Andrades A, Martorell-Marugán J, Haswell JR, Slack FJ, Carmona-Sáez P, Medina PP. The SWI/SNF complex regulates the expression of miR-222, a tumor suppressor microRNA in lung adenocarcinoma. Human Molecular Genetics. PMID 34240140 DOI: 10.1093/hmg/ddab187 |
0.695 |
|
| 2021 |
Li WJ, Wang Y, Liu R, Kasinski AL, Shen H, Slack FJ, Tang DG. MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic. Frontiers in Cell and Developmental Biology. 9: 640587. PMID 33763422 DOI: 10.3389/fcell.2021.640587 |
0.335 |
|
| 2020 |
Anastasiadou E, Seto A, Beatty X, Hermreck M, Gilles ME, Stroopinsky D, Pinter-Brown LC, Pestano L, Marchese C, Avigan D, Trivedi P, Escolar D, Jackson A, Slack FJ. Cobomarsen, an oligonucleotide inhibitor of miR-155, slows DLBCL tumor cell growth and . Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33208342 DOI: 10.1158/1078-0432.CCR-20-3139 |
0.313 |
|
| 2020 |
Malik S, Lim J, Slack FJ, Braddock DT, Bahal R. Next generation miRNA inhibition using short anti-seed PNAs encapsulated in PLGA nanoparticles. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 32835710 DOI: 10.1016/J.Jconrel.2020.08.026 |
0.479 |
|
| 2020 |
Foster DJ, Chang HM, Haswell JR, Gregory RI, Slack FJ. TRIM71 binds to IMP1 and is capable of positive and negative regulation of target RNAs. Cell Cycle (Georgetown, Tex.). 1-13. PMID 32816599 DOI: 10.1080/15384101.2020.1804232 |
0.303 |
|
| 2020 |
Segal M, Slack FJ. Challenges identifying efficacious miRNA therapeutics for cancer. Expert Opinion On Drug Discovery. 1-5. PMID 32421364 DOI: 10.1080/17460441.2020.1765770 |
0.531 |
|
| 2020 |
Nagarajan MB, Tentori AM, Zhang WC, Slack FJ, Doyle PS. Spatially resolved and multiplexed MicroRNA quantification from tissue using nanoliter well arrays. Microsystems & Nanoengineering. 6: 51. PMID 32419951 DOI: 10.1038/S41378-020-0169-8 |
0.48 |
|
| 2020 |
Ramírez-Moya J, Baker AR, Slack FJ, Santisteban P. ADAR1-mediated RNA editing is a novel oncogenic process in thyroid cancer and regulates miR-200 activity. Oncogene. PMID 32157211 DOI: 10.1038/S41388-020-1248-X |
0.463 |
|
| 2020 |
Rupaimoole R, Yoon B, Zhang WC, Adams BD, Slack FJ. A High-Throughput Small Molecule Screen Identifies Ouabain as Synergistic with miR-34a in Killing Lung Cancer Cells. Iscience. 23: 100878. PMID 32062455 DOI: 10.1016/J.Isci.2020.100878 |
0.422 |
|
| 2019 |
Segal M, Biscans A, Gilles ME, Anastasiadou E, De Luca R, Lim J, Khvorova A, Slack FJ. Hydrophobically Modified let-7b miRNA Enhances Biodistribution to NSCLC and Downregulates HMGA2 In Vivo. Molecular Therapy. Nucleic Acids. 19: 267-277. PMID 31855835 DOI: 10.1016/J.Omtn.2019.11.008 |
0.565 |
|
| 2019 |
Slack FJ, Chinnaiyan AM. The Role of Non-coding RNAs in Oncology. Cell. 179: 1033-1055. PMID 31730848 DOI: 10.1016/J.Cell.2019.10.017 |
0.347 |
|
| 2019 |
Witten L, Slack FJ. miR-155 as a novel clinical target for hematological malignancies. Carcinogenesis. PMID 31711135 DOI: 10.1093/Carcin/Bgz183 |
0.549 |
|
| 2019 |
Mavrikaki M, Pantano L, Potter D, Rogers-Grazado MA, Anastasiadou E, Slack FJ, Amr SS, Ressler KJ, Daskalakis NP, Chartoff E. Sex-Dependent Changes in miRNA Expression in the Bed Nucleus of the Stria Terminalis Following Stress. Frontiers in Molecular Neuroscience. 12: 236. PMID 31636537 DOI: 10.3389/Fnmol.2019.00236 |
0.458 |
|
| 2019 |
Zhang WC, Wells JM, Chow KH, Huang H, Yuan M, Saxena T, Melnick MA, Politi K, Asara JM, Costa DB, Bult CJ, Slack FJ. miR-147b-mediated TCA cycle dysfunction and pseudohypoxia initiate drug tolerance to EGFR inhibitors in lung adenocarcinoma. Nature Metabolism. 1: 460-474. PMID 31535082 DOI: 10.1038/s42255-019-0052-9 |
0.329 |
|
| 2019 |
Gilles ME, Hao L, Brown K, Lim J, Bhatia SN, Slack FJ. Tumor penetrating nanomedicine targeting both an oncomiR and an oncogene in pancreatic cancer. Oncotarget. 10: 5349-5358. PMID 31523393 DOI: 10.18632/Oncotarget.27160 |
0.454 |
|
| 2019 |
Mavrikaki M, Anastasiadou E, Ozdemir RA, Potter D, Helmholz C, Slack FJ, Chartoff EH. Overexpression of miR-9 in the nucleus accumbens increases oxycodone self-administration. The International Journal of Neuropsychopharmacology. PMID 30989210 DOI: 10.1093/Ijnp/Pyz015 |
0.454 |
|
| 2019 |
Phan D, Foster D, Jux B, Lake E, Constable T, Kolanus W, Slack F, Kahle KT. Trim71 Links an Ancient MicroRNA Pathway to Neural Stem Cell Development and Human Congenital Hydrocephalus Neurosurgery. 66. DOI: 10.1093/Neuros/Nyz310_649 |
0.3 |
|
| 2018 |
Jiao AL, Perales R, Umbreit NT, Haswell JR, Piper ME, Adams BD, Pellman D, Kennedy S, Slack FJ. Human Nuclear RNAi-Defective 2 (NRDE2) is an essential RNA splicing factor. Rna (New York, N.Y.). PMID 30538148 DOI: 10.1261/Rna.069773.118 |
0.678 |
|
| 2018 |
Witten LW, Cheng CJ, Slack FJ. miR-155 drives oncogenesis by promoting and cooperating with mutations in the c-Kit oncogene. Oncogene. PMID 30459357 DOI: 10.1038/S41388-018-0571-Y |
0.445 |
|
| 2018 |
Gilles ME, Slack FJ. Let-7 microRNA as a potential therapeutic target with implications for immunotherapy. Expert Opinion On Therapeutic Targets. 1-11. PMID 30328720 DOI: 10.1080/14728222.2018.1535594 |
0.549 |
|
| 2018 |
Choe J, Lin S, Zhang W, Liu Q, Wang L, Ramirez-Moya J, Du P, Kim W, Tang S, Sliz P, Santisteban P, George RE, Richards WG, Wong KK, Locker N, ... Slack FJ, et al. mRNA circularization by METTL3-eIF3h enhances translation and promotes oncogenesis. Nature. PMID 30232453 DOI: 10.1038/S41586-018-0538-8 |
0.36 |
|
| 2018 |
Nagarajan MB, Tentori AM, Zhang WC, Slack FJ, Doyle PS. Nonfouling, Encoded Hydrogel Microparticles for Multiplex MicroRNA Profiling Directly from Formalin-Fixed, Paraffin-Embedded Tissue. Analytical Chemistry. PMID 30106558 DOI: 10.1021/Acs.Analchem.8B02010 |
0.493 |
|
| 2018 |
Anastasiadou E, Faggioni A, Trivedi P, Slack FJ. The Nefarious Nexus of Noncoding RNAs in Cancer. International Journal of Molecular Sciences. 19. PMID 30018188 DOI: 10.3390/Ijms19072072 |
0.353 |
|
| 2018 |
Tentori AM, Nagarajan MB, Kim JJ, Zhang WC, Slack FJ, Doyle PS. Quantitative and multiplex microRNA assays from unprocessed cells in isolated nanoliter well arrays. Lab On a Chip. PMID 29998262 DOI: 10.1039/C8Lc00498F |
0.479 |
|
| 2018 |
Anastasiadou E, Stroopinsky D, Alimperti S, Jiao AL, Pyzer AR, Cippitelli C, Pepe G, Severa M, Rosenblatt J, Etna MP, Rieger S, Kempkes B, Coccia EM, Sui SJH, Chen CS, ... ... Slack FJ, et al. Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas. Leukemia. PMID 29946193 DOI: 10.1038/S41375-018-0178-X |
0.351 |
|
| 2018 |
Gilles ME, Hao L, Huang L, Rupaimoole R, Lopez-Casas PP, Pulver E, Jeong JC, Muthuswamy SK, Hidalgo M, Bhatia SN, Slack FJ. Personalized RNA-medicine for pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29330203 DOI: 10.1158/1078-0432.Ccr-17-2733 |
0.526 |
|
| 2018 |
Jiao AL, Foster DJ, Dixon J, Slack FJ. lin-4 and the NRDE pathway are required to activate a transgenic lin-4 reporter but not the endogenous lin-4 locus in C. elegans. Plos One. 13: e0190766. PMID 29324872 DOI: 10.1371/Journal.Pone.0190766 |
0.479 |
|
| 2018 |
Eleni A, Dina S, Alimperti S, Jiao A, Pyzer A, Cipitelli C, Severa M, Chen CS, Uccini S, Avigan D, Faggioni A, Trivedi P, Slack FJ. Abstract A16: Epstein-Barr virus encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B cell lymphomas Cancer Immunology Research. 6. DOI: 10.1158/2326-6074.Tumimm17-A16 |
0.328 |
|
| 2018 |
Lee Jw, Slack FJ, Nestler EJ, Herbst RS, Koo JP. Abstract 3334: CREB is required for KRAS-driven lung tumorigenesis Cancer Research. 78: 3334-3334. DOI: 10.1158/1538-7445.Am2018-3334 |
0.351 |
|
| 2017 |
Anastasiadou E, Jacob LS, Slack FJ. Non-coding RNA networks in cancer. Nature Reviews. Cancer. PMID 29170536 DOI: 10.1038/Nrc.2017.99 |
0.379 |
|
| 2017 |
Inukai S, Pincus Z, de Lencastre A, Slack FJ. A microRNA feedback loop regulates global microRNA abundance during aging. Rna (New York, N.Y.). PMID 29114017 DOI: 10.1261/Rna.062190.117 |
0.548 |
|
| 2017 |
Metheetrairut C, Ahuja Y, Slack FJ. acn-1, a C. elegans homologue of ACE, genetically interacts with the let-7 microRNA and other heterochronic genes. Cell Cycle (Georgetown, Tex.). 1-10. PMID 28933985 DOI: 10.1080/15384101.2017.1344798 |
0.407 |
|
| 2017 |
Pyzer AR, Stroopinsky D, Rosenblatt J, Anastasiadou E, Rajabi H, Washington A, Tagde A, Chu JH, Coll M, Jiao AL, Tsai LT, Tenen DE, Cole L, Palmer K, Ephraim A, ... ... Slack F, et al. MUC1 inhibition leads to decrease in PD-L1 levels via up-regulation of miRNAs. Leukemia. PMID 28555079 DOI: 10.1038/Leu.2017.163 |
0.412 |
|
| 2017 |
Adams BD, Parsons C, Walker L, Zhang WC, Slack FJ. Targeting noncoding RNAs in disease. The Journal of Clinical Investigation. 127: 761-771. PMID 28248199 DOI: 10.1172/Jci84424 |
0.403 |
|
| 2017 |
Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nature Reviews. Drug Discovery. PMID 28209991 DOI: 10.1038/Nrd.2016.246 |
0.56 |
|
| 2017 |
Stroopinsky D, Pyzer AR, Anastasiadou E, Rajabi H, Washington A, Tagde A, Coll M, Cole L, Palmer K, Somaiya P, Leaf RK, Nahas M, Apel A, Jain S, Joyce R, ... ... Slack F, et al. Abstract 54: MUC1-C regulates PD-L1 expression in acute myeloid leukemia, via downregulation of miRNAs Clinical Cancer Research. 23: 54-54. DOI: 10.1158/1557-3265.Hemmal17-54 |
0.487 |
|
| 2017 |
Zhang W, Slack F. MicroRNA-21 Mediates Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer Journal of Thoracic Oncology. 12: S1536. DOI: 10.1016/J.Jtho.2017.06.021 |
0.309 |
|
| 2016 |
Smith-Vikos T, Liu Z, Parsons C, Gorospe M, Ferrucci L, Gill TM, Slack FJ. A serum miRNA profile of human longevity: findings from the Baltimore Longitudinal Study of Aging (BLSA). Aging. PMID 27824314 DOI: 10.18632/aging.101106 |
0.84 |
|
| 2016 |
Rupaimoole R, Slack FJ. A role for miR-34 in colon cancer stem cell homeostasis. Stem Cell Investigation. 3: 42. PMID 27668249 DOI: 10.21037/Sci.2016.08.04 |
0.334 |
|
| 2016 |
Aigner A, Buesen R, Gant T, Gooderham N, Greim H, Hackermüller J, Hubesch B, Laffont M, Marczylo E, Meister G, Petrick JS, Rasoulpour RJ, Sauer UG, Schmidt K, Seitz H, ... Slack F, et al. Advancing the use of noncoding RNA in regulatory toxicology: Report of an ECETOC workshop. Regulatory Toxicology and Pharmacology : Rtp. PMID 27663666 DOI: 10.1016/J.Yrtph.2016.09.018 |
0.335 |
|
| 2016 |
Zhang WC, Slack FJ. ADARs Edit MicroRNAs to Promote Leukemic Stem Cell Activity. Cell Stem Cell. 19: 141-2. PMID 27494666 DOI: 10.1016/J.Stem.2016.07.012 |
0.302 |
|
| 2016 |
Svoronos AA, Engelman DM, Slack FJ. OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer. Cancer Research. PMID 27325641 DOI: 10.1158/0008-5472.Can-16-0359 |
0.559 |
|
| 2016 |
Metheetrairut C, Adams BD, Nallur S, Weidhaas JB, Slack FJ. cel-mir-237 and its homologue, hsa-miR-125b, modulate the cellular response to ionizing radiation. Oncogene. PMID 27321180 DOI: 10.1038/Onc.2016.222 |
0.694 |
|
| 2016 |
Salzman DW, Nakamura K, Nallur S, Dookwah MT, Metheetrairut C, Slack FJ, Weidhaas JB. miR-34 activity is modulated through 5'-end phosphorylation in response to DNA damage. Nature Communications. 7: 10954. PMID 26996824 DOI: 10.1038/Ncomms10954 |
0.85 |
|
| 2016 |
Kim M, Kogan N, Slack FJ. Cis-acting elements in its 3' UTR mediate post-transcriptional regulation of KRAS. Oncotarget. PMID 26930719 DOI: 10.18632/Oncotarget.7599 |
0.5 |
|
| 2016 |
Pyzer AR, Stroopinsky D, Rosenblatt J, Anastasiadou E, Rajabi H, Washington AJ, Tagde A, Coll MD, Cole L, Palmer KA, Somaiya P, Karp Leaf R, Nahas MR, Apel A, Jain S, ... ... Slack F, et al. MUC1-C Inhibition Leads to Decrease in PD-L1 Levels Via up-Regulation of Micro RNAs Blood. 128: 2871-2871. DOI: 10.1182/Blood.V128.22.2871.2871 |
0.503 |
|
| 2016 |
Fernández PP, Coira IF, Palomares EER, Romero OA, Metheetrairut C, Corral LB, Carretero J, Vidal EF, Celorrio MC, Zurita FR, Martín VS, Gavira CB, Cara JAL, Céspedes MS, Slack F, et al. Abstract 4479: Unveiling the relationship between the SWI/SNF chromatin remodeling complex and noncoding RNAs Cancer Research. 76: 4479-4479. DOI: 10.1158/1538-7445.Am2016-4479 |
0.47 |
|
| 2015 |
Adams BD, Wali VB, Cheng CJ, Inukai S, Booth CJ, Agarwal S, Rimm DL, Győrffy B, Santarpia L, Pusztai L, Saltzman WM, Slack FJ. miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple Negative Breast Cancer. Cancer Research. PMID 26676753 DOI: 10.1158/0008-5472.Can-15-2321 |
0.439 |
|
| 2015 |
Adams BD, Parsons C, Slack FJ. The tumor-suppressive and potential therapeutic functions of miR-34a in epithelial carcinomas. Expert Opinion On Therapeutic Targets. 1-17. PMID 26652031 DOI: 10.1517/14728222.2016.1114102 |
0.522 |
|
| 2015 |
Adams BD, Anastasiadou E, Esteller M, He L, Slack FJ. The Inescapable Influence of Noncoding RNAs in Cancer. Cancer Research. PMID 26567137 DOI: 10.1158/0008-5472.Can-15-1989 |
0.491 |
|
| 2015 |
de Lencastre A, Slack F. Discovery of Novel microRNAs in Aging Caenorhabditis elegans. Methods in Molecular Biology (Clifton, N.J.). 1343: 235-48. PMID 26420721 DOI: 10.1007/978-1-4939-2963-4_18 |
0.309 |
|
| 2015 |
Woodbury ME, Freilich RW, Cheng CJ, Asai H, Ikezu S, Boucher JD, Slack F, Ikezu T. miR-155 Is Essential for Inflammation-Induced Hippocampal Neurogenic Dysfunction. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 9764-81. PMID 26134658 DOI: 10.1523/Jneurosci.4790-14.2015 |
0.377 |
|
| 2015 |
McVeigh TP, Jung SY, Kerin MJ, Salzman DW, Nallur S, Nemec AA, Dookwah M, Sadofsky J, Paranjape T, Kelly O, Chan E, Miller N, Sweeney KJ, Zelterman D, Sweasy J, ... ... Slack FJ, et al. Estrogen withdrawal, increased breast cancer risk and the KRAS-variant. Cell Cycle (Georgetown, Tex.). 14: 2091-9. PMID 25961464 DOI: 10.1080/15384101.2015.1041694 |
0.781 |
|
| 2015 |
Stefani G, Chen X, Zhao H, Slack FJ. A novel mechanism of LIN-28 regulation of let-7 microRNA expression revealed by in vivo HITS-CLIP in C. elegans. Rna (New York, N.Y.). 21: 985-96. PMID 25805859 DOI: 10.1261/Rna.045542.114 |
0.42 |
|
| 2015 |
Stahlhut C, Slack FJ. Combinatorial Action of MicroRNAs let-7 and miR-34 Effectively Synergizes with Erlotinib to Suppress Non-small Cell Lung Cancer Cell Proliferation. Cell Cycle (Georgetown, Tex.). 14: 2171-80. PMID 25714397 DOI: 10.1080/15384101.2014.1003008 |
0.562 |
|
| 2015 |
Ling H, Vincent K, Pichler M, Fodde R, Berindan-Neagoe I, Slack FJ, Calin GA. Junk DNA and the long non-coding RNA twist in cancer genetics. Oncogene. PMID 25619839 DOI: 10.1038/Onc.2014.456 |
0.401 |
|
| 2015 |
Cheng CJ, Bahal R, Babar IA, Pincus Z, Barrera F, Liu C, Svoronos A, Braddock DT, Glazer PM, Engelman DM, Saltzman WM, Slack FJ. MicroRNA silencing for cancer therapy targeted to the tumour microenvironment. Nature. 518: 107-10. PMID 25409146 DOI: 10.1038/Nature13905 |
0.843 |
|
| 2015 |
Coira IF, Rufino-Palomares EE, Romero OA, Peinado P, Metheetrairut C, Boyero-Corral L, Carretero J, Farez-Vidal E, Cuadros M, Reyes-Zurita FJ, Lupiáñez JA, Sánchez-Cespedes M, Slack FJ, Medina PP. Expression inactivation of SMARCA4 by microRNAs in lung tumors. Human Molecular Genetics. 24: 1400-9. PMID 25355421 DOI: 10.1093/Hmg/Ddu554 |
0.751 |
|
| 2015 |
Kasinski AL, Kelnar K, Stahlhut C, Orellana E, Zhao J, Shimer E, Dysart S, Chen X, Bader AG, Slack FJ. A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer. Oncogene. 34: 3547-55. PMID 25174400 DOI: 10.1038/Onc.2014.282 |
0.553 |
|
| 2015 |
Chen X, Paranjape T, Stahlhut C, McVeigh T, Keane F, Nallur S, Miller N, Kerin M, Deng Y, Yao X, Zhao H, Weidhaas JB, Slack FJ. Targeted resequencing of the microRNAome and 3'UTRome reveals functional germline DNA variants with altered prevalence in epithelial ovarian cancer. Oncogene. 34: 2125-37. PMID 24909162 DOI: 10.1038/Onc.2014.117 |
0.631 |
|
| 2015 |
Adams BD, Pusztai L, Rimm DL, Slack FJ. Abstract P4-07-12: Re-introduction of tumor suppressor miR-34a harbors therapeutic efficacy in triple negative breast cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P4-07-12 |
0.413 |
|
| 2015 |
Adams BD, Wali V, Cheng C, Inukai S, Rimm D, Pusztai L, Saltzman M, Slack F. Abstract LB-300: Reintroduction of tumor-suppressor miR-34a shows therapeutic efficacy in triple-negative breast cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-300 |
0.411 |
|
| 2015 |
Engelman DM, Cheng CJ, Bahal R, Babar IA, Pincus Z, Barrera FN, Liu C, Svoronos A, Braddock DT, Glazer PM, Saltzman WM, Slack FJ. pHLIP® Targeting and Delivery of PNA to Silence MicroRNA in Tumor Cells§ Biophysical Journal. 108: 552a. DOI: 10.1016/J.Bpj.2014.11.3029 |
0.823 |
|
| 2014 |
Anastasiadou E, Slack FJ. Cancer. Malicious exosomes. Science (New York, N.Y.). 346: 1459-60. PMID 25525233 DOI: 10.1126/Science.Aaa4024 |
0.331 |
|
| 2014 |
Kim M, Slack FJ. MicroRNA-mediated regulation of KRAS in cancer. Journal of Hematology & Oncology. 7: 84. PMID 25433809 DOI: 10.1186/S13045-014-0084-2 |
0.569 |
|
| 2014 |
Smith-Vikos T, de Lencastre A, Inukai S, Shlomchik M, Holtrup B, Slack FJ. MicroRNAs mediate dietary-restriction-induced longevity through PHA-4/FOXA and SKN-1/Nrf transcription factors. Current Biology : Cb. 24: 2238-46. PMID 25242029 DOI: 10.1016/J.Cub.2014.08.013 |
0.822 |
|
| 2014 |
Gerstein MB, Rozowsky J, Yan KK, Wang D, Cheng C, Brown JB, Davis CA, Hillier L, Sisu C, Li JJ, Pei B, Harmanci AO, Duff MO, Djebali S, Alexander RP, ... ... Slack FJ, et al. Comparative analysis of the transcriptome across distant species. Nature. 512: 445-8. PMID 25164755 DOI: 10.1038/Nature13424 |
0.3 |
|
| 2014 |
Adams BD, Kasinski AL, Slack FJ. Aberrant regulation and function of microRNAs in cancer. Current Biology : Cb. 24: R762-76. PMID 25137592 DOI: 10.1016/J.Cub.2014.06.043 |
0.564 |
|
| 2014 |
Chu YD, Wang WC, Chen SA, Hsu YT, Yeh MW, Slack FJ, Chan SP. RACK-1 regulates let-7 microRNA expression and terminal cell differentiation in Caenorhabditis elegans. Cell Cycle (Georgetown, Tex.). 13: 1995-2009. PMID 24776851 DOI: 10.4161/Cc.29017 |
0.572 |
|
| 2014 |
Slack FJ. In this issue of Epigenetics: special focus on non-coding RNAs in epigenetic regulation. Epigenetics. 9: 1-2. PMID 24739672 DOI: 10.4161/Epi.27579 |
0.39 |
|
| 2014 |
Kim M, Chen X, Chin LJ, Paranjape T, Speed WC, Kidd KK, Zhao H, Weidhaas JB, Slack FJ. Extensive sequence variation in the 3' untranslated region of the KRAS gene in lung and ovarian cancer cases. Cell Cycle (Georgetown, Tex.). 13: 1030-40. PMID 24552817 DOI: 10.4161/Cc.27941 |
0.852 |
|
| 2014 |
Turner MJ, Jiao AL, Slack FJ. Autoregulation of lin-4 microRNA transcription by RNA activation (RNAa) in C. elegans. Cell Cycle (Georgetown, Tex.). 13: 772-81. PMID 24398561 DOI: 10.4161/Cc.27679 |
0.476 |
|
| 2014 |
Jiao AL, Slack FJ. RNA-mediated gene activation. Epigenetics. 9: 27-36. PMID 24185374 DOI: 10.4161/Epi.26942 |
0.315 |
|
| 2014 |
Weidhaas JB, Kim ES, Herbst RS, Yu J, Slack F, Blumenschein GR, Tsao AS, Wistuba II, Lee JJ, Papadimitrakopoulou V, Hong WK, Heymach J, Tran HT. The KRAS-variant and treatment response in BATTLE-1. Journal of Clinical Oncology. 32: 8135-8135. DOI: 10.1200/Jco.2014.32.15_Suppl.8135 |
0.588 |
|
| 2014 |
Cheng CJ, Engelman DM, Saltzman M, Slack FJ. Abstract 974: Targeting the tumor microenvironment with antimiRs that exploit oncomiR addiction in lymphoma Cancer Research. 74: 974-974. DOI: 10.1158/1538-7445.Am2014-974 |
0.455 |
|
| 2013 |
Stahlhut C, Slack FJ. MicroRNAs and the cancer phenotype: profiling, signatures and clinical implications. Genome Medicine. 5: 111. PMID 24373327 DOI: 10.1186/Gm516 |
0.556 |
|
| 2013 |
Kasinski A, Slack FJ. Small RNAs deliver a blow to ovarian cancer. Cancer Discovery. 3: 1220-1. PMID 24203953 DOI: 10.1158/2159-8290.Cd-13-0667 |
0.325 |
|
| 2013 |
Higgs G, Slack F. The multiple roles of microRNA-155 in oncogenesis. Journal of Clinical Bioinformatics. 3: 17. PMID 24073882 DOI: 10.1186/2043-9113-3-17 |
0.496 |
|
| 2013 |
Smith-Vikos T, Slack FJ. MicroRNAs circulate around Alzheimer's disease. Genome Biology. 14: 125. PMID 23889814 DOI: 10.1186/Gb-2013-14-7-125 |
0.772 |
|
| 2013 |
Lieberman J, Slack F, Pandolfi PP, Chinnaiyan A, Agami R, Mendell JT. Noncoding RNAs and cancer. Cell. 153: 9-10. PMID 23781554 DOI: 10.1016/J.Cell.2013.03.019 |
0.33 |
|
| 2013 |
Chen X, Slack FJ, Zhao H. Joint analysis of expression profiles from multiple cancers improves the identification of microRNA-gene interactions. Bioinformatics (Oxford, England). 29: 2137-45. PMID 23772050 DOI: 10.1093/Bioinformatics/Btt341 |
0.539 |
|
| 2013 |
Cheng CJ, Saltzman WM, Slack FJ. Canonical and non-canonical barriers facing antimiR cancer therapeutics. Current Medicinal Chemistry. 20: 3582-93. PMID 23745563 DOI: 10.2174/0929867311320290004 |
0.54 |
|
| 2013 |
Metheetrairut C, Slack FJ. MicroRNAs in the ionizing radiation response and in radiotherapy. Current Opinion in Genetics & Development. 23: 12-9. PMID 23453900 DOI: 10.1016/J.Gde.2013.01.002 |
0.509 |
|
| 2013 |
Inukai S, Slack F. MicroRNAs and the genetic network in aging. Journal of Molecular Biology. 425: 3601-8. PMID 23353823 DOI: 10.1016/J.Jmb.2013.01.023 |
0.537 |
|
| 2013 |
Hoffman AE, Liu R, Fu A, Zheng T, Slack F, Zhu Y. Targetome profiling, pathway analysis and genetic association study implicate miR-202 in lymphomagenesis. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 327-36. PMID 23334589 DOI: 10.1158/1055-9965.Epi-12-1131-T |
0.454 |
|
| 2013 |
Slack FJ. MicroRNAs regulate expression of oncogenes. Clinical Chemistry. 59: 325-6. PMID 22529108 DOI: 10.1373/Clinchem.2011.181016 |
0.584 |
|
| 2013 |
Kato M, Slack FJ. Ageing and the small, non-coding RNA world. Ageing Research Reviews. 12: 429-35. PMID 22504407 DOI: 10.1016/J.Arr.2012.03.012 |
0.331 |
|
| 2012 |
Kasinski AL, Slack FJ. Arresting the Culprit: Targeted Antagomir Delivery to Sequester Oncogenic miR-221 in HCC. Molecular Therapy. Nucleic Acids. 1: e12. PMID 23343881 DOI: 10.1038/Mtna.2012.2 |
0.449 |
|
| 2012 |
Chen PY, Qin L, Barnes C, Charisse K, Yi T, Zhang X, Ali R, Medina PP, Yu J, Slack FJ, Anderson DG, Kotelianski V, Wang F, Tellides G, Simons M. FGF regulates TGF-β signaling and endothelial-to-mesenchymal transition via control of let-7 miRNA expression. Cell Reports. 2: 1684-96. PMID 23200853 DOI: 10.1016/J.Celrep.2012.10.021 |
0.662 |
|
| 2012 |
Jiao A, Slack FJ. MicroRNAs micromanage themselves. Circulation Research. 111: 1395-7. PMID 23139285 DOI: 10.1161/Circresaha.112.281014 |
0.543 |
|
| 2012 |
Kasinski AL, Slack FJ. miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma. Cancer Research. 72: 5576-87. PMID 22964582 DOI: 10.1158/0008-5472.Can-12-2001 |
0.485 |
|
| 2012 |
Inukai S, de Lencastre A, Turner M, Slack F. Novel microRNAs differentially expressed during aging in the mouse brain. Plos One. 7: e40028. PMID 22844398 DOI: 10.1371/Journal.Pone.0040028 |
0.532 |
|
| 2012 |
Babar IA, Cheng CJ, Booth CJ, Liang X, Weidhaas JB, Saltzman WM, Slack FJ. Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma. Proceedings of the National Academy of Sciences of the United States of America. 109: E1695-704. PMID 22685206 DOI: 10.1073/Pnas.1201516109 |
0.814 |
|
| 2012 |
Cheng CJ, Slack FJ. The duality of oncomiR addiction in the maintenance and treatment of cancer. Cancer Journal (Sudbury, Mass.). 18: 232-7. PMID 22647359 DOI: 10.1097/Ppo.0B013E318258B75B |
0.563 |
|
| 2012 |
Hanna JA, Wimberly H, Kumar S, Slack F, Agarwal S, Rimm DL. Quantitative analysis of microRNAs in tissue microarrays by in situ hybridization. Biotechniques. 52: 235-45. PMID 22482439 DOI: 10.2144/000113837 |
0.576 |
|
| 2012 |
Inukai S, Slack FJ. MiR-33 connects cholesterol to the cell cycle. Cell Cycle (Georgetown, Tex.). 11: 1060-1. PMID 22391211 DOI: 10.4161/Cc.11.6.19786 |
0.358 |
|
| 2012 |
Stefani G, Slack FJ. A 'pivotal' new rule for microRNA-mRNA interactions. Nature Structural & Molecular Biology. 19: 265-6. PMID 22388780 DOI: 10.1038/Nsmb.2256 |
0.533 |
|
| 2012 |
Smith-Vikos T, Slack FJ. MicroRNAs and their roles in aging. Journal of Cell Science. 125: 7-17. PMID 22294612 DOI: 10.1242/Jcs.099200 |
0.843 |
|
| 2012 |
Russ R, Slack FJ. Cigarette-Smoke-Induced Dysregulation of MicroRNA Expression and Its Role in Lung Carcinogenesis. Pulmonary Medicine. 2012: 791234. PMID 22191027 DOI: 10.1155/2012/791234 |
0.494 |
|
| 2012 |
Kundu ST, Nallur S, Paranjape T, Boeke M, Weidhaas JB, Slack FJ. KRAS alleles: the LCS6 3'UTR variant and KRAS coding sequence mutations in the NCI-60 panel. Cell Cycle (Georgetown, Tex.). 11: 361-6. PMID 22189714 DOI: 10.4161/Cc.11.2.18794 |
0.671 |
|
| 2012 |
Ratner ES, Keane FK, Lindner R, Tassi RA, Paranjape T, Glasgow M, Nallur S, Deng Y, Lu L, Steele L, Sand S, Muller RU, Bignotti E, Bellone S, Boeke M, ... ... Slack FJ, et al. A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer. Oncogene. 31: 4559-66. PMID 22139083 DOI: 10.1038/Onc.2011.539 |
0.666 |
|
| 2012 |
Kasinski AL, Slack FJ. Abstract 2950: miR-34 preventsin vivolung tumor initiation and progression in the therapeutically resistant Kras;p53 mouse model Cancer Research. 72: 2950-2950. DOI: 10.1158/1538-7445.Am2012-2950 |
0.436 |
|
| 2012 |
Hoffman AE, Liu R, Zheng T, Fu A, Slack F, Zhu Y. Abstract 1652: Targetome profiling and genetic association analyses implicate miR-202 in follicular lymphomagenesis Cancer Research. 72: 1652-1652. DOI: 10.1158/1538-7445.Am2012-1652 |
0.504 |
|
| 2012 |
Slack FJ. Abstract IA1: microRNAs and lung cancer Clinical Cancer Research. 18: IA1-IA1. DOI: 10.1158/1078-0432.12Aacriaslc-Ia1 |
0.476 |
|
| 2011 |
Blum JS, Weller CE, Booth CJ, Babar IA, Liang X, Slack FJ, Saltzman WM. Prevention of K-Ras- and Pten-mediated intravaginal tumors by treatment with camptothecin-loaded PLGA nanoparticles. Drug Delivery and Translational Research. 1: 383-394. PMID 25419505 DOI: 10.1007/S13346-011-0038-Y |
0.758 |
|
| 2011 |
Van Wynsberghe PM, Chan SP, Slack FJ, Pasquinelli AE. Analysis of microRNA Expression and Function Methods in Cell Biology. 106: 219-252. PMID 22118279 DOI: 10.1016/B978-0-12-544172-8.00008-6 |
0.548 |
|
| 2011 |
Kasinski AL, Slack FJ. Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nature Reviews. Cancer. 11: 849-64. PMID 22113163 DOI: 10.1038/Nrc3166 |
0.572 |
|
| 2011 |
Landau DA, Slack FJ. MicroRNAs in mutagenesis, genomic instability, and DNA repair. Seminars in Oncology. 38: 743-51. PMID 22082760 DOI: 10.1053/J.Seminoncol.2011.08.003 |
0.523 |
|
| 2011 |
Babar IA, Czochor J, Steinmetz A, Weidhaas JB, Glazer PM, Slack FJ. Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells. Cancer Biology & Therapy. 12: 908-14. PMID 22027557 DOI: 10.4161/Cbt.12.10.17681 |
0.823 |
|
| 2011 |
Weidhaas JB, Slack FJ. KRAS rs61764370 in Epithelial Ovarian Cancer-Letter. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 6600; author reply 6. PMID 22003074 DOI: 10.1158/1078-0432.Ccr-11-1195 |
0.59 |
|
| 2011 |
Pincus Z, Smith-Vikos T, Slack FJ. MicroRNA predictors of longevity in Caenorhabditis elegans. Plos Genetics. 7: e1002306. PMID 21980307 DOI: 10.1371/Journal.Pgen.1002306 |
0.808 |
|
| 2011 |
Kato M, Chen X, Inukai S, Zhao H, Slack FJ. Age-associated changes in expression of small, noncoding RNAs, including microRNAs, in C. elegans. Rna (New York, N.Y.). 17: 1804-20. PMID 21810936 DOI: 10.1261/Rna.2714411 |
0.525 |
|
| 2011 |
Chan E, Patel R, Nallur S, Ratner E, Bacchiocchi A, Hoyt K, Szpakowski S, Godshalk S, Ariyan S, Sznol M, Halaban R, Krauthammer M, Tuck D, Slack FJ, Weidhaas JB. MicroRNA signatures differentiate melanoma subtypes. Cell Cycle (Georgetown, Tex.). 10: 1845-52. PMID 21543894 DOI: 10.4161/Cc.10.11.15777 |
0.847 |
|
| 2011 |
Kim M, Kasinski AL, Slack FJ. MicroRNA therapeutics in preclinical cancer models. The Lancet. Oncology. 12: 319-21. PMID 21463831 DOI: 10.1016/S1470-2045(11)70067-5 |
0.419 |
|
| 2011 |
Paranjape T, Heneghan H, Lindner R, Keane FK, Hoffman A, Hollestelle A, Dorairaj J, Geyda K, Pelletier C, Nallur S, Martens JW, Hooning MJ, Kerin M, Zelterman D, Zhu Y, ... ... Slack F, et al. A 3'-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis. The Lancet. Oncology. 12: 377-86. PMID 21435948 DOI: 10.1016/S1470-2045(11)70044-4 |
0.669 |
|
| 2011 |
Trang P, Wiggins JF, Daige CL, Cho C, Omotola M, Brown D, Weidhaas JB, Bader AG, Slack FJ. Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 1116-22. PMID 21427705 DOI: 10.1038/Mt.2011.48 |
0.71 |
|
| 2011 |
Pelletier C, Speed WC, Paranjape T, Keane K, Blitzblau R, Hollestelle A, Safavi K, van den Ouweland A, Zelterman D, Slack FJ, Kidd KK, Weidhaas JB. Rare BRCA1 haplotypes including 3'UTR SNPs associated with breast cancer risk. Cell Cycle (Georgetown, Tex.). 10: 90-9. PMID 21191178 DOI: 10.4161/Cc.10.1.14359 |
0.618 |
|
| 2011 |
Lu ZJ, Yip KY, Wang G, Shou C, Hillier LW, Khurana E, Agarwal A, Auerbach R, Rozowsky J, Cheng C, Kato M, Miller DM, Slack F, Snyder M, Waterston RH, et al. Prediction and characterization of noncoding RNAs in C. elegans by integrating conservation, secondary structure, and high-throughput sequencing and array data. Genome Research. 21: 276-85. PMID 21177971 DOI: 10.1101/Gr.110189.110 |
0.321 |
|
| 2011 |
Godshalk SE, Paranjape T, Nallur S, Speed W, Chan E, Molinaro AM, Bacchiocchi A, Hoyt K, Tworkoski K, Stern DF, Sznol M, Ariyan S, Lazova R, Halaban R, Kidd KK, ... ... Slack FJ, et al. A Variant in a MicroRNA complementary site in the 3' UTR of the KIT oncogene increases risk of acral melanoma. Oncogene. 30: 1542-50. PMID 21119596 DOI: 10.1038/Onc.2010.536 |
0.849 |
|
| 2011 |
Weidhaas J, Slack F, Miller N, Harris L, Tuck D, Zhu Y, Zelterman D, Kerin M, Paranjape T, Heneghan H, Lindner R, Keane F, Dorairaj J, Geyda K, Pelletier C, et al. Association between KRAS rs61764370 and triple-negative breast cancer-a false positive? - Authors' reply The Lancet Oncology. 12: 724. DOI: 10.1016/S1470-2045(11)70163-2 |
0.564 |
|
| 2011 |
Ratner E, Keane F, Yu H, Zelterman D, Rutherford T, Santin A, Schwartz P, Slack F, Levine D, Weidhaas J. A 3′ UTR KRAS variant as a biomarker of poor outcome and chemotherapy resistance in ovarian cancer (Gynecologic Oncology (2011) 120, (S3)) Gynecologic Oncology. 122: 205. DOI: 10.1016/J.Ygyno.2011.03.028 |
0.586 |
|
| 2011 |
Ratner E, Keane F, Yu H, Zelterman D, Rutherford T, Santin A, Schwartz P, Slack F, Levine D, Weidhaas J. RETRACTED: A 3’ UTR KRAS variant as a biomarker of poor outcome and chemotherapy resistance in ovarian cancer Gynecologic Oncology. 120: S3. DOI: 10.1016/J.Ygyno.2010.12.010 |
0.572 |
|
| 2010 |
de Lencastre A, Pincus Z, Zhou K, Kato M, Lee SS, Slack FJ. MicroRNAs both promote and antagonize longevity in C. elegans. Current Biology : Cb. 20: 2159-68. PMID 21129974 DOI: 10.1016/J.Cub.2010.11.015 |
0.517 |
|
| 2010 |
Medina PP, Nolde M, Slack FJ. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature. 467: 86-90. PMID 20693987 DOI: 10.1038/Nature09284 |
0.847 |
|
| 2010 |
Hada K, Asahina M, Hasegawa H, Kanaho Y, Slack FJ, Niwa R. The nuclear receptor gene nhr-25 plays multiple roles in the Caenorhabditis elegans heterochronic gene network to control the larva-to-adult transition. Developmental Biology. 344: 1100-9. PMID 20678979 DOI: 10.1016/J.Ydbio.2010.05.508 |
0.343 |
|
| 2010 |
Ratner E, Lu L, Boeke M, Barnett R, Nallur S, Chin LJ, Pelletier C, Blitzblau R, Tassi R, Paranjape T, Hui P, Godwin AK, Yu H, Risch H, Rutherford T, ... ... Slack FJ, et al. A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk. Cancer Research. 70: 6509-15. PMID 20647319 DOI: 10.1158/0008-5472.Can-10-0689 |
0.811 |
|
| 2010 |
Kasinski AL, Slack FJ. Potential microRNA therapies targeting Ras, NFkappaB and p53 signaling. Current Opinion in Molecular Therapeutics. 12: 147-57. PMID 20373258 |
0.458 |
|
| 2010 |
Kundu ST, Slack FJ. Robust and specific inhibition of microRNAs in Caenorhabditis elegans. Journal of Biology. 9: 20. PMID 20359318 DOI: 10.1186/Jbiol230 |
0.556 |
|
| 2010 |
Godshalk SE, Melnik-Martinez KV, Pasquinelli AE, Slack FJ. MicroRNAs and cancer: a meeting summary of the eponymous Keystone Conference. Epigenetics. 5: 164-8. PMID 20168081 DOI: 10.4161/Epi.5.2.11162 |
0.854 |
|
| 2010 |
Slack FJ. Stem cells: Big roles for small RNAs. Nature. 463: 616. PMID 20130638 DOI: 10.1038/463616A |
0.34 |
|
| 2010 |
Trang P, Medina PP, Wiggins JF, Ruffino L, Kelnar K, Omotola M, Homer R, Brown D, Bader AG, Weidhaas JB, Slack FJ. Regression of murine lung tumors by the let-7 microRNA. Oncogene. 29: 1580-7. PMID 19966857 DOI: 10.1038/Onc.2009.445 |
0.798 |
|
| 2010 |
Paranjape TS, Heneghan H, Pelletier C, Hoffman A, Kerin MJ, Harris L, Zhu Y, Miller N, Zelterman D, Tuck D, Slack F, Weidhaas J. Abstract 3029: A KRAS microRNA binding site polymorphism as a novel biomarker of risk in triple negative breast cancer Cancer Research. 70: 3029-3029. DOI: 10.1158/1538-7445.Am10-3029 |
0.726 |
|
| 2010 |
Weidhaas JB, Slack F. Abstract 1856: A KRAS-variant as a putative biomarker of ovarian cancer risk Cancer Research. 70: 1856-1856. DOI: 10.1158/1538-7445.Am10-1856 |
0.62 |
|
| 2010 |
Heneghan H, Miller N, Paranjape T, Slack F, Weidhaas J, Kerin M. O-43 A KRAS microRNA binding site variant is a genetic marker of risk for triple negative breast cancer European Journal of Cancer Supplements. 8: 16. DOI: 10.1016/J.Ejcsup.2010.06.044 |
0.599 |
|
| 2009 |
Niwa R, Hada K, Moliyama K, Ohniwa RL, Tan YM, Olsson-Carter K, Chi W, Reinke V, Slack FJ. C. elegans sym-1 is a downstream target of the hunchback-like-1 developmental timing transcription factor. Cell Cycle (Georgetown, Tex.). 8: 4147-54. PMID 19923914 DOI: 10.4161/Cc.8.24.10292 |
0.419 |
|
| 2009 |
Paranjape T, Slack FJ, Weidhaas JB. MicroRNAs: Tools for cancer diagnostics Gut. 58: 1546-1554. PMID 19834118 DOI: 10.1136/Gut.2009.179531 |
0.742 |
|
| 2009 |
Roush SF, Slack FJ. Transcription of the C. elegans let-7 microRNA is temporally regulated by one of its targets, hbl-1. Developmental Biology. 334: 523-34. PMID 19627983 DOI: 10.1016/J.Ydbio.2009.07.012 |
0.815 |
|
| 2009 |
Chan SP, Slack FJ. Ribosomal protein RPS-14 modulates let-7 microRNA function in Caenorhabditis elegans. Developmental Biology. 334: 152-60. PMID 19627982 DOI: 10.1016/J.Ydbio.2009.07.011 |
0.544 |
|
| 2009 |
Hoffman AE, Zheng T, Yi C, Leaderer D, Weidhaas J, Slack F, Zhang Y, Paranjape T, Zhu Y. microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Research. 69: 5970-7. PMID 19567675 DOI: 10.1158/0008-5472.Can-09-0236 |
0.724 |
|
| 2009 |
Kato M, de Lencastre A, Pincus Z, Slack FJ. Dynamic expression of small non-coding RNAs, including novel microRNAs and piRNAs/21U-RNAs, during Caenorhabditis elegans development. Genome Biology. 10: R54. PMID 19460142 DOI: 10.1186/Gb-2009-10-5-R54 |
0.423 |
|
| 2009 |
Kato M, Paranjape T, Müller RU, Ullrich R, Nallur S, Gillespie E, Keane K, Esquela-Kerscher A, Weidhaas JB, Slack FJ. The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells. Oncogene. 28: 2419-24. PMID 19421141 DOI: 10.1038/Onc.2009.106 |
0.845 |
|
| 2009 |
Slack F. let-7 microRNA reduces tumor growth. Cell Cycle (Georgetown, Tex.). 8: 1823. PMID 19377282 DOI: 10.4161/Cc.8.12.8639 |
0.364 |
|
| 2009 |
Nimmo RA, Slack FJ. An elegant miRror: microRNAs in stem cells, developmental timing and cancer. Chromosoma. 118: 405-18. PMID 19340450 DOI: 10.1007/S00412-009-0210-Z |
0.491 |
|
| 2009 |
Corbin R, Olsson-Carter K, Slack F. The role of microRNAs in synaptic development and function. Bmb Reports. 42: 131-5. PMID 19335998 DOI: 10.5483/Bmbrep.2009.42.3.131 |
0.476 |
|
| 2009 |
Medina PP, Slack FJ. Inhibiting microRNA function in vivo. Nature Methods. 6: 37-8. PMID 19116612 DOI: 10.1038/Nmeth0109-37 |
0.762 |
|
| 2009 |
Turner MJ, Slack FJ. Transcriptional control of microRNA expression in C. elegans: promoting better understanding. Rna Biology. 6: 49-53. PMID 19106630 DOI: 10.4161/Rna.6.1.7574 |
0.558 |
|
| 2009 |
Duchaine TF, Slack FJ. RNA interference and micro-RNA-oriented therapy in cancer: Rationales, promises, and challenges Current Oncology. 16: 61-66. DOI: 10.3747/Co.V16I4.486 |
0.452 |
|
| 2009 |
Paranjape T, Nallur S, Keanie K, Martel M, Haffty B, Tuck D, Slack F, Weidhaas J. MicroRNA profiling of triple negative breast cancer: predicting outcome and targets. Cancer Research. 69: 2040. DOI: 10.1158/0008-5472.Sabcs-2040 |
0.613 |
|
| 2008 |
Trang P, Weidhaas JB, Slack FJ. MicroRNAs as potential cancer therapeutics Oncogene. 27. PMID 19956180 DOI: 10.1038/Onc.2009.353 |
0.736 |
|
| 2008 |
Maller Schulman BR, Liang X, Stahlhut C, DelConte C, Stefani G, Slack FJ. The let-7 microRNA target gene, Mlin41/Trim71 is required for mouse embryonic survival and neural tube closure. Cell Cycle (Georgetown, Tex.). 7: 3935-42. PMID 19098426 DOI: 10.4161/Cc.7.24.7397 |
0.505 |
|
| 2008 |
Slack FJ, Weidhaas JB. MicroRNA in cancer prognosis. The New England Journal of Medicine. 359: 2720-2. PMID 19092157 DOI: 10.1056/Nejme0808667 |
0.669 |
|
| 2008 |
Godshalk SE, Bhaduri-McIntosh S, Slack FJ. Epstein-Barr virus-mediated dysregulation of human microRNA expression. Cell Cycle (Georgetown, Tex.). 7: 3595-600. PMID 19001862 DOI: 10.4161/Cc.7.22.7120 |
0.85 |
|
| 2008 |
Chin LJ, Ratner E, Leng S, Zhai R, Nallur S, Babar I, Muller RU, Straka E, Su L, Burki EA, Crowell RE, Patel R, Kulkarni T, Homer R, Zelterman D, ... ... Slack FJ, et al. A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. Cancer Research. 68: 8535-40. PMID 18922928 DOI: 10.1158/0008-5472.Can-08-2129 |
0.805 |
|
| 2008 |
Chin LJ, Slack FJ. A truth serum for cancer--microRNAs have major potential as cancer biomarkers. Cell Research. 18: 983-4. PMID 18833286 DOI: 10.1038/Cr.2008.290 |
0.76 |
|
| 2008 |
Pincus Z, Slack FJ. Transcriptional (dys)regulation and aging in Caenorhabditis elegans. Genome Biology. 9: 233. PMID 18828877 DOI: 10.1186/Gb-2008-9-9-233 |
0.307 |
|
| 2008 |
Ding XC, Slack FJ, Grosshans H. The let-7 microRNA interfaces extensively with the translation machinery to regulate cell differentiation. Cell Cycle (Georgetown, Tex.). 7: 3083-90. PMID 18818519 DOI: 10.4161/Cc.7.19.6778 |
0.533 |
|
| 2008 |
Roush S, Slack FJ. The let-7 family of microRNAs. Trends in Cell Biology. 18: 505-16. PMID 18774294 DOI: 10.1016/J.Tcb.2008.07.007 |
0.842 |
|
| 2008 |
Medina PP, Slack FJ. microRNAs and cancer: an overview. Cell Cycle (Georgetown, Tex.). 7: 2485-92. PMID 18719380 DOI: 10.4161/Cc.7.16.6453 |
0.786 |
|
| 2008 |
Chan SP, Ramaswamy G, Choi EY, Slack FJ. Identification of specific let-7 microRNA binding complexes in Caenorhabditis elegans. Rna (New York, N.Y.). 14: 2104-14. PMID 18719242 DOI: 10.1261/Rna.551208 |
0.432 |
|
| 2008 |
Büssing I, Slack FJ, Grosshans H. let-7 microRNAs in development, stem cells and cancer. Trends in Molecular Medicine. 14: 400-9. PMID 18674967 DOI: 10.1016/J.Molmed.2008.07.001 |
0.55 |
|
| 2008 |
Babar IA, Slack FJ, Weidhaas JB. miRNA modulation of the cellular stress response. Future Oncology (London, England). 4: 289-98. PMID 18407740 DOI: 10.2217/14796694.4.2.289 |
0.831 |
|
| 2008 |
Esquela-Kerscher A, Trang P, Wiggins JF, Patrawala L, Cheng A, Ford L, Weidhaas JB, Brown D, Bader AG, Slack FJ. The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle (Georgetown, Tex.). 7: 759-64. PMID 18344688 DOI: 10.4161/Cc.7.6.5834 |
0.81 |
|
| 2008 |
Stefani G, Slack FJ. Small non-coding RNAs in animal development. Nature Reviews. Molecular Cell Biology. 9: 219-30. PMID 18270516 DOI: 10.1038/Nrm2347 |
0.484 |
|
| 2008 |
Niwa R, Zhou F, Li C, Slack FJ. The expression of the Alzheimer's amyloid precursor protein-like gene is regulated by developmental timing microRNAs and their targets in Caenorhabditis elegans. Developmental Biology. 315: 418-25. PMID 18262516 DOI: 10.1016/J.Ydbio.2007.12.044 |
0.35 |
|
| 2008 |
Kato M, Slack FJ. microRNAs: small molecules with big roles - C. elegans to human cancer. Biology of the Cell / Under the Auspices of the European Cell Biology Organization. 100: 71-81. PMID 18199046 DOI: 10.1042/Bc20070078 |
0.563 |
|
| 2007 |
Weidhaas JB, Babar I, Nallur SM, Trang P, Roush S, Boehm M, Gillespie E, Slack FJ. MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer Research. 67: 11111-6. PMID 18056433 DOI: 10.1158/0008-5472.Can-07-2858 |
0.826 |
|
| 2007 |
Chan SP, Slack FJ. And now introducing mammalian mirtrons. Developmental Cell. 13: 605-7. PMID 17981129 DOI: 10.1016/J.Devcel.2007.10.010 |
0.313 |
|
| 2007 |
Johnson CD, Esquela-Kerscher A, Stefani G, Byrom M, Kelnar K, Ovcharenko D, Wilson M, Wang X, Shelton J, Shingara J, Chin L, Brown D, Slack FJ. The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Research. 67: 7713-22. PMID 17699775 DOI: 10.1158/0008-5472.Can-07-1083 |
0.808 |
|
| 2007 |
Nolde MJ, Saka N, Reinert KL, Slack FJ. The Caenorhabditis elegans pumilio homolog, puf-9, is required for the 3'UTR-mediated repression of the let-7 microRNA target gene, hbl-1. Developmental Biology. 305: 551-63. PMID 17412319 DOI: 10.1016/J.Ydbio.2007.02.040 |
0.83 |
|
| 2007 |
Niwa R, Slack FJ. The evolution of animal microRNA function. Current Opinion in Genetics & Development. 17: 145-50. PMID 17317150 DOI: 10.1016/J.Gde.2007.02.004 |
0.545 |
|
| 2007 |
Weidhaas J, Slack F, Babar I, Nallur S. Using MicroRNAs to Alter the Radiation Response International Journal of Radiation Oncology*Biology*Physics. 69: S145-S146. DOI: 10.1016/J.Ijrobp.2007.07.266 |
0.781 |
|
| 2006 |
Stahlhut Espinosa CE, Slack FJ. The role of microRNAs in cancer. The Yale Journal of Biology and Medicine. 79: 131-40. PMID 17940623 |
0.398 |
|
| 2006 |
Stefani G, Slack F. MicroRNAs in search of a target Cold Spring Harbor Symposia On Quantitative Biology. 71: 129-134. PMID 17381288 DOI: 10.1101/Sqb.2006.71.032 |
0.495 |
|
| 2006 |
Chan SP, Slack FJ. microRNA-mediated silencing inside P-bodies. Rna Biology. 3: 97-100. PMID 17179742 DOI: 10.4161/Rna.3.3.3499 |
0.326 |
|
| 2006 |
Roush SF, Slack FJ. Micromanagement: a role for microRNAs in mRNA stability. Acs Chemical Biology. 1: 132-4. PMID 17163657 DOI: 10.1021/Cb600138J |
0.799 |
|
| 2006 |
Boehm M, Slack FJ. MicroRNA control of lifespan and metabolism. Cell Cycle (Georgetown, Tex.). 5: 837-40. PMID 16627994 DOI: 10.4161/Cc.5.8.2688 |
0.81 |
|
| 2006 |
Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nature Reviews. Cancer. 6: 259-69. PMID 16557279 DOI: 10.1038/Nrc1840 |
0.842 |
|
| 2006 |
Slack FJ, Weidhaas JB. MicroRNAs as a potential magic bullet in cancer. Future Oncology (London, England). 2: 73-82. PMID 16556074 DOI: 10.2217/14796694.2.1.73 |
0.725 |
|
| 2006 |
Boehm M, Slack F. A developmental timing microRNA and its target regulate life span in C. elegans. Science (New York, N.Y.). 310: 1954-7. PMID 16373574 DOI: 10.1126/Science.1115596 |
0.795 |
|
| 2005 |
Vella MC, Slack FJ. C. elegans microRNAs. Wormbook : the Online Review of C. Elegans Biology. 1-9. PMID 18050425 DOI: 10.1895/Wormbook.1.26.1 |
0.797 |
|
| 2005 |
Schulman BR, Esquela-Kerscher A, Slack FJ. Reciprocal expression of lin-41 and the microRNAs let-7 and mir-125 during mouse embryogenesis. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 234: 1046-54. PMID 16247770 DOI: 10.1002/Dvdy.20599 |
0.84 |
|
| 2005 |
Esquela-Kerscher A, Johnson SM, Bai L, Saito K, Partridge J, Reinert KL, Slack FJ. Post-embryonic expression of C. elegans microRNAs belonging to the lin-4 and let-7 families in the hypodermis and the reproductive system. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 234: 868-77. PMID 16217741 DOI: 10.1002/Dvdy.20572 |
0.822 |
|
| 2005 |
Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D, Slack FJ. RAS is regulated by the let-7 microRNA family. Cell. 120: 635-47. PMID 15766527 DOI: 10.1016/J.Cell.2005.01.014 |
0.456 |
|
| 2005 |
Grosshans H, Johnson T, Reinert KL, Gerstein M, Slack FJ. The temporal patterning microRNA let-7 regulates several transcription factors at the larval to adult transition in C. elegans. Developmental Cell. 8: 321-30. PMID 15737928 DOI: 10.1016/J.Devcel.2004.12.019 |
0.417 |
|
| 2005 |
Banerjee D, Kwok A, Lin SY, Slack FJ. Developmental timing in C. elegans is regulated by kin-20 and tim-1, homologs of core circadian clock genes. Developmental Cell. 8: 287-95. PMID 15691769 DOI: 10.1016/J.Devcel.2004.12.006 |
0.305 |
|
| 2004 |
Esquela-Kerscher A, Slack FJ. The age of high-throughput microRNA profiling. Nature Methods. 1: 106-7. PMID 15782171 DOI: 10.1038/Nmeth1104-106 |
0.764 |
|
| 2004 |
Vella MC, Reinert K, Slack FJ. Architecture of a validated microRNA::target interaction. Chemistry & Biology. 11: 1619-23. PMID 15610845 DOI: 10.1016/J.Chembiol.2004.09.010 |
0.742 |
|
| 2004 |
Vella MC, Choi EY, Lin SY, Reinert K, Slack FJ. The C. elegans microRNA let-7 binds to imperfect let-7 complementary sites from the lin-41 3'UTR. Genes & Development. 18: 132-7. PMID 14729570 DOI: 10.1101/Gad.1165404 |
0.752 |
|
| 2003 |
Johnson SM, Lin SY, Slack FJ. The time of appearance of the C. elegans let-7 microRNA is transcriptionally controlled utilizing a temporal regulatory element in its promoter. Developmental Biology. 259: 364-79. PMID 12871707 DOI: 10.1016/S0012-1606(03)00202-1 |
0.452 |
|
| 2003 |
Lin SY, Johnson SM, Abraham M, Vella MC, Pasquinelli A, Gamberi C, Gottlieb E, Slack FJ. The C elegans hunchback homolog, hbl-1, controls temporal patterning and is a probable microRNA target. Developmental Cell. 4: 639-50. PMID 12737800 DOI: 10.1016/S1534-5807(03)00124-2 |
0.755 |
|
| 2002 |
Ramaswamy G, Slack FJ. siRNA. A guide for RNA silencing. Chemistry & Biology. 9: 1053-5. PMID 12401489 DOI: 10.1016/S1074-5521(02)00249-1 |
0.3 |
|
| 2002 |
Banerjee D, Slack F. Control of developmental timing by small temporal RNAs: a paradigm for RNA-mediated regulation of gene expression. Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 24: 119-29. PMID 11835276 DOI: 10.1002/Bies.10046 |
0.358 |
|
| 2002 |
Grosshans H, Slack FJ. Micro-RNAs: small is plentiful. The Journal of Cell Biology. 156: 17-21. PMID 11781331 DOI: 10.1083/Jcb.200111033 |
0.484 |
|
| 2000 |
Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda MI, Maller B, Hayward DC, Ball EE, Degnan B, Müller P, Spring J, Srinivasan A, Fishman M, Finnerty J, Corbo J, et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature. 408: 86-9. PMID 11081512 DOI: 10.1038/35040556 |
0.556 |
|
| 2000 |
Slack FJ, Basson M, Liu Z, Ambros V, Horvitz HR, Ruvkun G. The lin-41 RBCC gene acts in the C. elegans heterochronic pathway between the let-7 regulatory RNA and the LIN-29 transcription factor. Molecular Cell. 5: 659-69. PMID 10882102 DOI: 10.1016/S1097-2765(00)80245-2 |
0.688 |
|
| 2000 |
Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR, Ruvkun G. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature. 403: 901-6. PMID 10706289 DOI: 10.1038/35002607 |
0.682 |
|
| 1999 |
Miyabayashi T, Palfreyman MT, Sluder AE, Slack F, Sengupta P. Expression and function of members of a divergent nuclear receptor family in Caenorhabditis elegans Developmental Biology. 215: 314-331. PMID 10545240 DOI: 10.1006/Dbio.1999.9470 |
0.325 |
|
| 1998 |
Slack F, Ruvkun G. Heterochronic genes in development and evolution. The Biological Bulletin. 195: 375-6. PMID 9924779 DOI: 10.2307/1543152 |
0.548 |
|
| 1998 |
Slack FJ, Ruvkun G. A novel repeat domain that is often associated with RING finger and B-box motifs. Trends in Biochemical Sciences. 23: 474-5. PMID 9868369 DOI: 10.1016/S0968-0004(98)01299-7 |
0.483 |
|
| 1997 |
Slack F, Ruvkun G. Temporal pattern formation by heterochronic genes. Annual Review of Genetics. 31: 611-34. PMID 9442909 DOI: 10.1146/Annurev.Genet.31.1.611 |
0.56 |
|
| 1995 |
Slack FJ, Serror P, Joyce E, Sonenshein AL. A gene required for nutritional repression of the Bacillus subtilis dipeptide permease operon Molecular Microbiology. 15: 689-702. PMID 7783641 DOI: 10.1111/J.1365-2958.1995.Tb02378.X |
0.536 |
|
| 1993 |
Slack FJ, Mueller JP, Sonenshein AL. Mutations that relieve nutritional repression of the Bacillus subtilis dipeptide permease operon Journal of Bacteriology. 175: 4605-4614. PMID 8335620 DOI: 10.1128/Jb.175.15.4605-4614.1993 |
0.549 |
|
| 1991 |
Mueller JP, Mathiopoulos C, Slack FJ, Sonenshein AL. Identification of Bacillus subtilis adaptive response genes by subtractive differential hybridization Research in Microbiology. 142: 805-813. PMID 1784820 DOI: 10.1016/0923-2508(91)90059-J |
0.554 |
|
| 1991 |
Slack FJ, Mueller JP, Strauch MA, Mathiopoulos C, Sonenshein AL. Transcriptional regulation of a Bacillus subtilis dipeptide transport operon Molecular Microbiology. 5: 1915-1925. PMID 1766371 DOI: 10.1111/J.1365-2958.1991.Tb00815.X |
0.572 |
|
| 1991 |
Mathiopoulos C, Mueller JP, Slack FJ, Murphy CG, Patankar S, Bukusoglu G, Sonenshein AL. A Bacillus subtilis dipeptide transport system expressed early during sporulation Molecular Microbiology. 5: 1903-1913. PMID 1766370 DOI: 10.1111/J.1365-2958.1991.Tb00814.X |
0.521 |
|
| Show low-probability matches. |
